Cyrille Leperlier
Director/Miembro de la Junta en NUCANA PLC .
Fortuna: - $ al 31/03/2024
Perfil
Cyrille Raymond George Leperlier is currently the Chief Executive Officer at Divlal SAS since 2020 and an Independent Non-Executive Director at NuCana Plc since 2018.
Previously, he worked as a Medical Director at Rhone-Poulenc Rorer, Inc. and Sanofi-Aventis Japan from 2004 to 2019, where he held the position of Medical Director from 2014 to 2019.
He obtained a graduate and doctorate degree from the University of Paris Jussieu.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NUCANA PLC
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Cyrille Leperlier
Empresas | Cargo | Inicio |
---|---|---|
NUCANA PLC | Director/Miembro de la Junta | 01/05/2018 |
Divlal SAS | Director Ejecutivo | 01/06/2020 |
Antiguos cargos conocidos de Cyrille Leperlier.
Empresas | Cargo | Fin |
---|---|---|
Sanofi-Aventis Japan | Director Técnico/Científico/I+D | 01/12/2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Director Técnico/Científico/I+D | - |
Formación de Cyrille Leperlier.
University of Paris Jussieu | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NUCANA PLC | Health Technology |
Empresas privadas | 3 |
---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Sanofi-Aventis Japan | |
Divlal SAS |
- Bolsa de valores
- Insiders
- Cyrille Leperlier